- Rosetta Genomics' (ROSG) shares are +9% after saying that its Cancer Origin Test is being covered by Highmark Health Services, the fourth largest U.S. Blue Cross and Blue Shield-Affiliated company.
- Highmark has 5.3M members in Pennsylvania, Delaware and West Virginia. The test is now available to one in five people in the U.S.
- The product tests for the origin of tumors in Cancer of Unknown or Uncertain Primary (CUP). (PR)
Rosetta cancer test receives coverage at major health insurer
Jan 21 2014, 09:48 ET